Esperion Therapeutics, Inc. · NASDAQ:ESPR
Looker Benjamin sold 11,824 Esperion Therapeutics, Inc. shares (Form 4)
Traded Jun 17, 2026 · Filed Jun 18, 2026
On Jun 17, 2026, Looker Benjamin (Chief Legal Officer) sold 11,824 Esperion Therapeutics, Inc. shares at US$3.16 for US$37,364, leaving 667,524 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 11,824 shares
- Price
- US$3.16
- Value
- US$37,364
- Holding after
- 667,524 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | Sale | 11,824 | US$3.16 | 667,524 | Direct |
Source
Related
- Esperion Therapeutics, Inc.
- Looker Benjamin
- Esperion Therapeutics, Inc. shareholders
- Form 4 · Looker Benjamin · Jul 13, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026